Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro
By: Rui Liu, Cuihong Jiang, Zhizheng Zhao, Yutong Lv and Gaoxing Wang
Authors
Rui Liu
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus), Beijing, China
Cuihong Jiang
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus), Beijing, China
Zhizheng Zhao
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus), Beijing, China
Yutong Lv
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus), Beijing, China
Gaoxing Wang
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus), Beijing, China
Language: English
Page range: 269 - 280
Accepted on: Dec 3, 2022
Published on: Jun 12, 2023
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2023 Rui Liu, Cuihong Jiang, Zhizheng Zhao, Yutong Lv, Gaoxing Wang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.